Chemotherapy, not androgen receptor-targeted therapy should be used upfront for metastatic hormone-sensitive prostate cancer. CON: Novel oral agents provide an attractive alternative to chemotherapy in metastatic hormone-sensitive prostate cancer.
作者信息
Condon Benjamin, Liskaser Grace, Thangasamy Isaac A, Murphy Declan G
机构信息
Division of Cancer Surgery, Peter MacCallum Cancer Centre.
Faculty of Medicine, University of Melbourne, Melbourne, Victoria.
出版信息
Curr Opin Urol. 2020 Jul;30(4):620-622. doi: 10.1097/MOU.0000000000000694.
PMID:31725005
Abstract
摘要
Zotero 插件